Clicky

Revenio Group Oyj(REVXF)

Description: Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.


Keywords: Ophthalmology Macular Degeneration Glaucoma Diabetic Retinopathy Blindness Retinopathy Imaging Devices Confocal Retinal Imaging Eye Care Software Platform I Care Ic100

Home Page: www.reveniogroup.fi

Aeyritie 22
Vantaa, 01510
Finland
Phone: 358 9877 51150


Officers

Name Title
Mr. Jouni Toijala B.Sc., M.B.A. President & CEO
Mr. Robin Pulkkinen M.Sc., M.Sc. (Econ) Chief Financial Officer
Mr. Ari Isomäki Vice President of Operations
Mr. Tomi Karvo M.B.A., M.Sc. Vice President of Products, Brand & Marketing
Mr. John Floyd Vice President of Sales
Ms. Hanna Vuornos Vice President of People & Culture
Kate Taylor Vice President of Strategy & Business Development

Exchange: OTCGREY

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 32.1543
Trailing PE: 37.3026
Price-to-Book MRQ: 6.6902
Price-to-Sales TTM: 8.2012
IPO Date:
Fiscal Year End: December
Full Time Employees: 230
Back to stocks